Dr. Saira Ahmed, MD

Dr. Ahmed practices at Ascension Saint Agnes Hospital in Baltimore, Maryland, part of Ascension Health Alliance.

Dr. Ahmed's NPI, 1932393766, was assigned on September 5, 2007. Dr. Ahmed holds Maryland license D72915.

Dr. Ahmed's primary practice is Ascension Saint Agnes Hospital, at 900 Caton Avenue, Baltimore, MD 21229 in Baltimore City. The practice phone is (410) 368-6000.

Dr. Ahmed's primary practice is Ascension Saint Agnes Hospital in Baltimore, Maryland, part of Ascension Health Alliance. The medical group on file is Integrated Specialists Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ahmed practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ahmed's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ahmed is licensed in Maryland.

CMS data shows 746 Medicare services from Dr. Ahmed across 5 procedure codes in 2024, for 230 Medicare patients. Medicare paid $62,535 for them.

CMS counts 230 Medicare patients who saw Dr. Ahmed in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ahmed's median patient age at 67, with 68% women.

In 2024, Dr. Ahmed wrote 503 Medicare Part D claims for 92 patients. 63% of them were for generic drugs. CMS names the drug for 328 of them, across 13 drugs with 11 or more claims each, at $1,149,896 in total drug cost. In 2023, CMS named 425 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ahmed for performance year 2024, reported as part of a group. Dr. Ahmed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ahmed as offering telehealth.

Dmand AI links 13 papers to Dr. Ahmed, published from 2010 to 2024. 2011 was the busiest year, with 2. The most frequent topics are Cell Line, Tumor, DNA Methylation and Gene Expression Regulation, Neoplastic. Dr. Ahmed has published most often in Cancer Res. Dr. Ahmed's most frequent co-authors are Jean-Pierre Issa, MD, Jeffrey J. Molldrem, MD and Richard E. Champlin, MD.

CMS Open Payments shows 35 general payments to Dr. Ahmed from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Rigel Pharmaceuticals, Inc. paid the most, $3,798.